SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-22-007045
Filing Date
2022-11-03
Accepted
2022-11-03 07:44:50
Documents
8
Period of Report
2022-11-03

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_110322.htm 6-K 9457
2 EXHIBIT 99.1 exh_991.htm EX-99.1 8083
3 EXHIBIT 99.2 exh_992.htm EX-99.2 8395
4 EXHIBIT 99.3 exh_993.htm EX-99.3 10111
5 EXHIBIT 99.4 exh_994.htm EX-99.4 8555
6 EXHIBIT 99.5 exh_995.htm EX-99.5 13289
7 EXHIBIT 99.6 exh_996.htm EX-99.6 7036
8 EXHIBIT 99.7 exh_997.htm EX-99.7 717009
  Complete submission text file 0001171843-22-007045.txt   783030
Mailing Address 45 MESPIL ROAD DUBLIN 4 L2 D04 W2F1
Business Address DEPT 920A, 196 HIGH ROAD WOOD GREEN LONDON X0 N22 8HH 353-1-518-0200
Amryt Pharma plc (Filer) CIK: 0001783010 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39365 | Film No.: 221356276
SIC: 2834 Pharmaceutical Preparations